Finance

Lists
Why is 300584 down 2,26%?
Dive Deeper
300584:SHE
Nanjing Hicin Pharmaceutical Co Ltd
CNÂ¥27,74
-2,26%
(-0,64) 1D
16 Okt., 15:04:52 GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 300584...
Open
CNÂ¥28,68
High
CNÂ¥29,38
Low
CNÂ¥27,51
Mkt. cap
3,70 mjd
Avg. vol.
3,17 m
Volume
3,96 m
Dividend
0,36%
Quarterly dividend
CNÂ¥0,02
Ex-dividend date
25 Jun. 2026
P/E ratio
74,03
52-wk high
CNÂ¥73,40
52-wk low
CNÂ¥27,51
EPS
CNÂ¥0,37
Shares outstanding
120,00 m
No. of employees
553
Open
CNÂ¥28,68
High
CNÂ¥29,38
Low
CNÂ¥27,51
Mkt. cap
3,70 mjd
Avg. vol.
3,17 m
Volume
3,96 m
Dividend
0,36%
Quarterly dividend
CNÂ¥0,02
Ex-dividend date
25 Jun. 2026
P/E ratio
74,03
52-wk high
CNÂ¥73,40
52-wk low
CNÂ¥27,51
EPS
CNÂ¥0,37
Shares outstanding
120,00 m
No. of employees
553
News stories
From web sources and news partners
About Nanjing Hicin Pharmaceutical Co Ltd
CEO-
Employees553
Founded15 Jan. 2003
Headquarters-
SectorPharmaceutical industry
Websitehicin.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep. 2025
Des. 2025
Mrt. 2026
Jun. 2026
Revenue
162,95 m
199,52 m
160,34 m
203,81 m
Cost of goods sold
25,46 m
45,82 m
34,56 m
70,49 m
Cost of revenue
25,46 m
45,82 m
34,56 m
70,49 m
Research and development expenses
14,30 m
9,25 m
4,51 m
5,38 m
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
102,58 m
109,20 m
98,16 m
95,67 m
Operating expense
119,51 m
125,33 m
105,61 m
106,31 m
Total operating expenses
144,98 m
171,15 m
140,17 m
176,80 m
Operating income
17,98 m
28,37 m
20,17 m
27,01 m
Other non operating income
34,15 k
-33,85 k
-240,85 k
191,17 k
EBT including unusual items
3,52 m
12,45 m
14,98 m
23,02 m
EBT excluding unusual items
16,60 m
26,63 m
18,49 m
25,94 m
Income tax expense
203,45 k
3,91 m
-1,35 m
6,46 m
Effective tax rate
5,78%
31,43%
-9,01%
28,05%
Other operating expenses
3,33 m
5,07 m
3,42 m
3,03 m
Net income
3,52 m
9,38 m
17,36 m
14,70 m
Net profit margin
2,16%
4,70%
10,83%
7,21%
Earnings per share
-
-
-
-
Interest and investment income
12,03 k
9,56 k
10,29 k
6,23 k
Interest expense
-1,40 m
-1,73 m
-1,45 m
-1,26 m
Net interest expenses
-1,39 m
-1,72 m
-1,44 m
-1,25 m
Depreciation and amortization charges
-
-
-
-
EBITDA
31,19 m
44,35 m
36,14 m
44,77 m
Gain or loss from assets sale
482,28 k
-482,28 k
-
1,07 k
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google-programme